These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23999252)

  • 21. Tumour and normal tissue radiosensitivity.
    Lapierre A; Gourgou S; Brengues M; Quéro L; Deutsch É; Milliat F; Riou O; Azria D
    Cancer Radiother; 2022; 26(1-2):96-103. PubMed ID: 34953704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential for the G2/M arrest assay to predict patient susceptibility to severe reactions following radiotherapy.
    Perez A; Grabenbauer GG; Sprung CN; Sauer R; Distel LV
    Strahlenther Onkol; 2007 Feb; 183(2):99-106. PubMed ID: 17294115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of radiation-induced late effects: What's new?].
    Chargari C; Supiot S; Hennequin C; Chapel A; Simon JM
    Cancer Radiother; 2020 Oct; 24(6-7):602-611. PubMed ID: 32855027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal tissue radiosensitivity in breast cancer patients.
    Ramsay J; Birrell G
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):339-44. PubMed ID: 7836087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes.
    Lacombe J; Azria D; Mange A; Solassol J
    Expert Rev Proteomics; 2013 Feb; 10(1):33-42. PubMed ID: 23414358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
    Bentzen SM; Overgaard M; Overgaard J
    Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
    Dunst J; Gebhart E; Neubauer S
    Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variation in normal tissue toxicity induced by ionizing radiation.
    Popanda O; Marquardt JU; Chang-Claude J; Schmezer P
    Mutat Res; 2009 Jul; 667(1-2):58-69. PubMed ID: 19022265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients.
    Strasser H; Grabenbauer GG; Sprung CN; Sauer R; Distel LV
    Strahlenther Onkol; 2007 Aug; 183(8):447-53. PubMed ID: 17680225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal tissue tolerance dose metrics for radiation therapy of major organs.
    Milano MT; Constine LS; Okunieff P
    Semin Radiat Oncol; 2007 Apr; 17(2):131-40. PubMed ID: 17395043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors.
    Alsbeih G; Malone S; Lochrin C; Girard A; Fertil B; Raaphorst GP
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):143-52. PubMed ID: 10656386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between pulsed-field gel electrophoresis and the comet assay as predictive assays for radiosensitivity in fibroblasts.
    Sarkaria JN; Bush C; Eady JJ; Peacock JH; Steel GG; Yarnold JR
    Radiat Res; 1998 Jul; 150(1):17-22. PubMed ID: 9650597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro.
    Wilkins RC; Ng CE; Raaphorst GP
    Radiat Oncol Investig; 1998; 6(5):209-15. PubMed ID: 9822167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and cellular radiosensitivity in inherited human syndromes.
    Leong T; Borg M; McKay M
    Clin Oncol (R Coll Radiol); 2004 May; 16(3):206-9. PubMed ID: 15191009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy.
    West CM
    Br J Radiol; 1995 Aug; 68(812):827-37. PubMed ID: 7551778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological modulation of late radio-induced side effects].
    Bourgier C; Monceau V; Bourhis J; Deutsch E; Vozenin MC
    Cancer Radiother; 2011 Aug; 15(5):383-9. PubMed ID: 21596606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of in vitro lymphocyte radiosensitivity and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer.
    Finnon P; Kabacik S; MacKay A; Raffy C; A'Hern R; Owen R; Badie C; Yarnold J; Bouffler S
    Radiother Oncol; 2012 Dec; 105(3):329-36. PubMed ID: 23157981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
    López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
    Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T lymphocytes to predict radiation-induced late effects in normal tissues.
    Brengues M; Lapierre A; Bourgier C; Pèlegrin A; Özsahin M; Azria D
    Expert Rev Mol Diagn; 2017 Feb; 17(2):119-127. PubMed ID: 27936985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity.
    Zschenker O; Raabe A; Boeckelmann IK; Borstelmann S; Szymczak S; Wellek S; Rades D; Hoeller U; Ziegler A; Dikomey E; Borgmann K
    Radiother Oncol; 2010 Oct; 97(1):26-32. PubMed ID: 20170971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.